Healthcare


 What’s Behind Oncolytics Biotech’s Stock Movement?

What’s Behind Oncolytics Biotech’s Stock Movement?

December 27, 2024 08:49 PM AEDT| By Team Kalkine Media

Highlights,Oncolytics Biotech Inc.,shares,recently surpassed their 200-day moving average.,The company focuses on developing treatments for cancer, with its lead product in phase 3 clinical trials.,Key financial metrics include a significant market c...

 What’s Behind Spectral Medical’s Recent Stock Price Drop

What’s Behind Spectral Medical’s Recent Stock Price Drop

December 25, 2024 02:53 AM AEDT| By Team Kalkine Media

Highlights:,Stock of Spectral Medical (TSX:EDT) drops below its fifty-day moving average.,Company reports a quarterly loss, with low earnings.,Spectral Medical focuses on treatments for septic shock and related conditions.,Spectral Medical Inc.,(TSX:...

 Why Is Tenet Announcing a Leadership Shake-Up for Its Finance Team?

Why Is Tenet Announcing a Leadership Shake-Up for Its Finance Team?

December 23, 2024 11:18 PM AEDT| By Team Kalkine Media

Highlights,Tenet CFO Jean Landreville retires at the end of 2024,Maxime Couturier named as Tenet’s new Chief Financial Officer,Couturier brings significant financial expertise to Tenet’s leadership,Tenet,(TSX:PKK),operates within the healthcare secto...

 Is Well Health Technologies Facing an Unexpected Market Challenge?

Is Well Health Technologies Facing an Unexpected Market Challenge?

December 23, 2024 11:15 PM AEDT| By Team Kalkine Media

Highlights:,Well Health Technologies leads Canada's outpatient medical clinics.,Expansion in telehealth services bolsters company's digital offerings.,Recent stock performance shows significant growth within a month.,Well Health Technologies,(TSX:WEL...

 Can This Healthcare Stock Overcome Its Performance Hurdles?

Can This Healthcare Stock Overcome Its Performance Hurdles?

December 20, 2024 11:24 PM AEDT| By Team Kalkine Media

Highlights,Quipt Home Medical focuses on durable and home medical equipment across the United States.,The firm has a diverse product portfolio, including respiratory and non-invasive ventilation devices.,Recent market performance reflects stability d...

 Charlotte's Web (TSX:CWEB) Struggling With Revenue Decline Amidst Market Challenges

Charlotte's Web (TSX:CWEB) Struggling With Revenue Decline Amidst Market Challenges

December 20, 2024 02:55 AM AEDT| By Team Kalkine Media

Highlights:,Charlotte's Web faces a sharp decline in its stock price over the past year.,Despite industry growth, the company has experienced a significant drop in revenue.,P/S ratio aligns with industry standards, but future outlook remains weak.,Ch...

 Organigram (TSX:OGI) Faces Adjusted Price Target Amidst Steady Performance

Organigram (TSX:OGI) Faces Adjusted Price Target Amidst Steady Performance

December 19, 2024 01:30 AM AEDT| By Team Kalkine Media

Highlights:,Organigram receives a revised price target following recent stock performance.,The company continues to show steady movement in the cannabis market.,Organigram offers a diverse portfolio of cannabis products under multiple brands.,Organig...

 Sienna Senior Living (TSX:SIA) Anticipates Solid Earnings and Growth Amid Expanding Dividend Strategy

Sienna Senior Living (TSX:SIA) Anticipates Solid Earnings and Growth Amid Expanding Dividend Strategy

December 19, 2024 12:15 AM AEDT| By Team Kalkine Media

Highlights:,Sienna Senior Living expects strong earnings for the upcoming quarter.,The company has increased its dividend payout, offering an attractive yield.,There remains optimism about Sienna’s growth prospects in the senior care sector.,Sienna S...

 Could This Immunotherapy Reveal New Paths for Treating Complex Cancers?

Could This Immunotherapy Reveal New Paths for Treating Complex Cancers?

December 18, 2024 11:47 PM AEDT| By Team Kalkine Media

Highlights,Oncolytics Biotech to present new data at ASCO Symposium,Focus on pelareorep in challenging gastrointestinal cancers,Data acceptance highlights clinical-stage advancements,Oncolytics Biotech Inc.,(TSX:ONC),operates within the oncology sect...

 Why Might Extendicare’s Dividend Not Be Sustainable?

Why Might Extendicare’s Dividend Not Be Sustainable?

December 18, 2024 02:24 AM AEDT| By Team Kalkine Media

Highlights,Extendicare Inc. will pay CA$0.04 per share on January 15th.,The dividend yield of 4.7% aligns with industry norms.,The company has a solid history of dividend payments and sustainable earnings growth.,Extendicare Inc.,(TSX:EXE),, a promin...

 Why Is Medical Facilities Outpacing the Healthcare Sector?

Why Is Medical Facilities Outpacing the Healthcare Sector?

December 17, 2024 07:52 PM AEDT| By Team Kalkine Media

Highlights,Specialty hospitals and surgery centers operate across the United States.,Revenue reached $441.27 million through healthcare services.,Q3 2024 net income rebounded to US$7.25 million.,Medical Facilities Corporation,(TSX:DR),is a notable en...

 Cloud DX Announces Sale of Cloud Diagnostics Canada ULC as Part of Restructuring Efforts

Cloud DX Announces Sale of Cloud Diagnostics Canada ULC as Part of Restructuring Efforts

December 17, 2024 05:02 PM AEDT| By Team Kalkine Media

Highlights,Cloud DX sells its wholly owned subsidiary, Cloud Diagnostics Canada ULC, following a court-approved restructuring.,The transaction follows the notice of intention to make a proposal (NOI) and a reverse vesting order (RVO).,A new entity, 1...

 Could Cipher Pharmaceuticals Be Overextending Its Financial Limits

Could Cipher Pharmaceuticals Be Overextending Its Financial Limits

December 14, 2024 02:30 AM AEDT| By Team Kalkine Media

Highlights,Cipher Pharmaceuticals has seen a significant increase in debt, reaching a net debt level that may require close attention.,Despite the increase in debt, the company has a strong interest cover, suggesting its debt load is manageable under...

 LifeSpeak’s Financial Challenges A Close Look At Debt And Liabilities

LifeSpeak’s Financial Challenges A Close Look At Debt And Liabilities

December 14, 2024 02:06 AM AEDT| By Team Kalkine Media

Highlights:,LifeSpeak's liabilities exceed its cash and receivables, presenting financial challenges.,The company has incurred significant losses, with a concerning EBIT deficit.,LifeSpeak’s debt-heavy structure may require recapitalization in the ne...

 Aurora Cannabis (TSX:ACB) Maintains Focus Amid Market Activity

Aurora Cannabis (TSX:ACB) Maintains Focus Amid Market Activity

December 13, 2024 11:40 PM AEDT| By Team Kalkine Media

Highlights,Aurora Cannabis stock shows fluctuations with notable insider activity.,Senior Officer trades shares at above-market price levels.,Company focuses on cannabis production, propagation, and CBD distribution.,Aurora Cannabis,(TSX:ACB),, a pro...

 Fennec Pharmaceuticals (TSX:FRX) Experiences Slight Stock Decline

Fennec Pharmaceuticals (TSX:FRX) Experiences Slight Stock Decline

December 13, 2024 11:34 PM AEDT| By Team Kalkine Media

Highlights,Fennec Pharmaceuticals shows slight decline in stock price.,Insider activity includes purchase of shares by a Senior Officer.,The company focuses on pediatric cancer treatments, with a key product aimed at preventing platinum-induced ototo...

 Kovo HealthTech's Strategic Fundraising Initiatives To Drive Growth

Kovo HealthTech's Strategic Fundraising Initiatives To Drive Growth

December 13, 2024 05:24 PM AEDT| By Team Kalkine Media

Highlights,Kovo,HealthTech launches a private placement to raise funds.,A concurrent offering focuses on corporate operational needs.,Both initiatives align with the company's growth strategy.,Kovo HealthTech Corporation,(TSXV:KOVO),, a healthcare te...

 Knight Therapeutics (TSX: GUD) Receives Regulatory Approval for TAVALISSE® in Mexico for Treatment of Chronic ITP

Knight Therapeutics (TSX: GUD) Receives Regulatory Approval for TAVALISSE® in Mexico for Treatment of Chronic ITP

December 13, 2024 01:19 AM AEDT| By Team Kalkine Media

Highlights,Grupo Biotoscana de Especialidad S.A. de C.V., has received regulatory approval from COFEPRIS for TAVALISSE® (fostamatinib disodium hexahydrate).,The approval is for the treatment of thrombocytopenia in adult patients with chronic immune t...

 How Medicus Pharma Is Redefining SCC Treatment for Horses with D-MNA

How Medicus Pharma Is Redefining SCC Treatment for Horses with D-MNA

December 13, 2024 12:13 AM AEDT| By Team Kalkine Media

Highlights:,Medicus Pharma Ltd.has received Minor Use in Major Species Designation (MUMS) from the FDA for its Doxorubicin-containing microneedle array (D-MNA) to treat equine squamous cell carcinoma.,The MUMS designation allows the company an exclus...

 What’s Driving Insider Activity at Dentalcorp Holdings?

What’s Driving Insider Activity at Dentalcorp Holdings?

December 12, 2024 11:45 PM AEDT| By Team Kalkine Media

Highlights:,Insider activity at Dentalcorp Holdings Ltd. indicates a net buying trend over the past year.,The stock has seen insiders purchasing more shares than they have sold.,Such transactions may provide some insight into the company’s internal p...

Canadian AI All-Stars: Unveiling the Top Stocks for 2025

Send OTP Resend OTP in 30s

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.